Literature DB >> 25345493

Response of refractory Ewing sarcoma to pazopanib.

Thierry Alcindor1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25345493     DOI： 10.3109/0284186X.2014.971938

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  15 in total

1.  Phase Ib/II Study of the Safety and Efficacy of Combination Therapy with Multikinase VEGF Inhibitor Pazopanib and MEK Inhibitor Trametinib In Advanced Soft Tissue Sarcoma.

Authors:  Vivek Subbiah; Christian Meyer; Ralph Zinner; Funda Meric-Bernstam; Marianna L Zahurak; Ashley O'Connor; Jason Roszik; Kenna Shaw; Joseph A Ludwig; Razelle Kurzrock; Nilofer A Azad
Journal:  Clin Cancer Res       Date:  2017-04-04       Impact factor: 12.531

2.  Remission of a Primary, Recurrent Thoracic Ewing Sarcoma in a 74-year-old woman.

Authors:  Robert M Tungate; Kristi Lara; Dakshesh Patel; Alexander Fedenko; James Hu
Journal:  Rare Tumors       Date:  2022-07-04

Review 3.  Advances in the Management of Pediatric Sarcomas.

Authors:  Fiorela N Hernandez Tejada; Alejandro Zamudio; Mario L Marques-Piubelli; Branko Cuglievan; Douglas Harrison
Journal:  Curr Oncol Rep       Date:  2020-11-16       Impact factor: 5.075

Review 4.  Pazopanib in the management of advanced soft tissue sarcomas.

Authors:  Lee D Cranmer; Elizabeth T Loggers; Seth M Pollack
Journal:  Ther Clin Risk Manag       Date:  2016-06-09       Impact factor: 2.423

Review 5.  Treatment pathway of bone sarcoma in children, adolescents, and young adults.

Authors:  Damon R Reed; Masanori Hayashi; Lars Wagner; Odion Binitie; Diana A Steppan; Andrew S Brohl; Eric T Shinohara; Julia A Bridge; David M Loeb; Scott C Borinstein; Michael S Isakoff
Journal:  Cancer       Date:  2017-03-21       Impact factor: 6.860

6.  Adrenal Ewing's Sarcoma in an Elderly Man.

Authors:  Kazuyoshi Toda; Sumiyasu Ishii; Hidetoshi Yasuoka; Masaki Nishioka; Takayuki Kobayashi; Kazuhiko Horiguchi; Takuya Tomaru; Atsushi Ozawa; Nobuyuki Shibusawa; Tetsurou Satoh; Hiromi Koshi; Atsuki Segawa; Shin-Ichi Shimizu; Tetsunari Oyama; Masanobu Yamada
Journal:  Intern Med       Date:  2017-12-21       Impact factor: 1.271

7.  Clinical study of apatinib in the treatment of stage IV osteogenic sarcoma after failure of chemotherapy.

Authors:  Zhichao Liao; Ting Li; Chao Zhang; Xinyue Liu; Ruwei Xing; Sheng Teng; Yun Yang; Gang Zhao; Xu Bai; Jun Zhao; Jilong Yang
Journal:  Cancer Biol Med       Date:  2020-05-15       Impact factor: 4.248

8.  Clinical Activity of Pazopanib in Metastatic Extraosseous Ewing Sarcoma.

Authors:  Steven Attia; Scott H Okuno; Steven I Robinson; Nicholas P Webber; Daniel J Indelicato; Robin L Jones; Sanjay P Bagaria; Robin L Jones; Courtney Sherman; Kevin R Kozak; Cherise M Cortese; Thomas McFarland; Jonathan C Trent; Robert G Maki
Journal:  Rare Tumors       Date:  2015-05-21

9.  Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell Tumor.

Authors:  Brian A Menegaz; Branko Cuglievan; Jalen Benson; Pamela Camacho; Salah-Eddine Lamhamedi-Cherradi; Cheuk Hong Leung; Carla L Warneke; Winston Huh; Vivek Subbiah; Robert S Benjamin; Shreyaskumar Patel; Najat Daw; Andrea Hayes-Jordan; Joseph A Ludwig
Journal:  Oncologist       Date:  2017-12-06

10.  Anlotinib, Vincristine, and Irinotecan for Advanced Ewing Sarcoma After Failure of Standard Multimodal Therapy: A Two-Cohort, Phase Ib/II Trial.

Authors:  Jie Xu; Lu Xie; Xin Sun; Kuisheng Liu; Xiaodong Tang; Taiqiang Yan; Rongli Yang; Wei Guo; Jin Gu
Journal:  Oncologist       Date:  2021-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.